Voyager Therapeutics (VYGR) Capital Expenditures (2014 - 2026)
Voyager Therapeutics (VYGR) reported Capital Expenditures of $14,000 for Q1 2026, down 97.9% from $658,000 a year earlier and down 97.8% from the prior quarter.
Powered by 
Analysis
Voyager Therapeutics (VYGR) Capital Expenditures (2014 - 2026) Analysis & Trends
For FY2025, Voyager Therapeutics posted Capital Expenditures of $2.6 million, down 26.3% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -26.5% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $3.52 million in FY2024 (+8.1%), $3.26 million in FY2023 (+30.7%), $2.49 million in FY2022 (+54.8%) and $1.61 million in FY2021 (-86.7%).
- The Q1 2026 figure ranks as the lowest quarterly Capital Expenditures in data going back to Q4 2014.
- Year over year, Capital Expenditures gained in two of the last eight quarters, with an average decline of 4.4%.
- The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 447.1%); the low point was Q1 2026 (a decline of 97.9%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $626,000 (Q4 2025), $207,000 (Q3 2025) and $1.11 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Voyager Therapeutics | 161.76 Mn | -501.43 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 626,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 658,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Sep 30, 2024 | 258,000.00 |
| Jun 30, 2024 | 967,000.00 |
| Mar 31, 2024 | 2.14 Mn |
| Dec 31, 2023 | 755,000.00 |
| Sep 30, 2023 | 782,000.00 |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 509,000.00 |
| Dec 31, 2022 | 933,000.00 |
| Sep 30, 2022 | 278,000.00 |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 347,000.00 |
| Sep 30, 2021 | 660,000.00 |
| Jun 30, 2021 | 227,000.00 |
API Access
Voyager Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VYGR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "VYGR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VYGR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();